William D. Humphries
2017
In 2017, William D. Humphries earned a total compensation of $8.4M as Executive Vice President, Company Group Chairman, at Valeant Pharmaceuticals International.
Compensation breakdown
| Bonus | $3,000,000 |
|---|---|
| Non-Equity Incentive Plan | $551,250 |
| Option Awards | $899,995 |
| Salary | $750,000 |
| Stock Awards | $3,225,011 |
| Other | $7,950 |
| Total | $8,434,206 |
Humphries received $3.2M in stock awards, accounting for 38% of the total pay in 2017.
Humphries also received $3M in bonus, $551.3K in non-equity incentive plan, $900K in option awards, $750K in salary and $8K in other compensation.
Rankings
In 2017, William D. Humphries' compensation ranked 876th out of 14,666 executives tracked by ExecPay. In other words, Humphries earned more than 94.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 876 out of 14,666 | 94th |
Division Manufacturing | 297 out of 5,772 | 95th |
Major group Chemicals And Allied Products | 75 out of 2,075 | 96th |
Industry group Drugs | 52 out of 1,731 | 97th |
Industry Pharmaceutical Preparations | 42 out of 1,333 | 97th |
Source: SEC filing on March 21, 2018.
Humphries' colleagues
We found four more compensation records of executives who worked with William D. Humphries at Valeant Pharmaceuticals International in 2017.
2017
Joseph Papa
Valeant Pharmaceuticals International
Chief Executive Officer
2017
Thomas Appio
Valeant Pharmaceuticals International
Group Chairman
2017
Christina Ackermann
Valeant Pharmaceuticals International
General Counsel
2017
Paul Herendeen
Valeant Pharmaceuticals International